Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lymphomes de l'Adulte.
作者:
主题词
抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);中枢神经系统肿瘤(Central Nervous System Neoplasms);女(雌)性(Female);人类(Humans);注射, 脊髓(Injections, Spinal);Logistic模型(Logistic Models);淋巴瘤, 非霍奇金(Lymphoma, Non-Hodgkin);男(雄)性(Male);甲氨蝶呤(Methotrexate);中年人(Middle Aged);多元分析(Multivariate Analysis);预后(Prognosis);危险因素(Risk Factors);二级预防(Secondary Prevention);存活率分析(Survival Analysis)
DOI
10.1023/a:1008394827806
PMID
10942056
发布时间
2022-03-16
- 浏览17

Annals of oncology
685-90页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文